Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 27.93
(-0.78%)
CNY 27.93
(-0.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.3 Billion CNY | -461.19% |
| 2022 | -588.93 Million CNY | 83.13% |
| 2021 | -3.48 Billion CNY | -342.95% |
| 2020 | 1.43 Billion CNY | 16.43% |
| 2019 | 1.23 Billion CNY | 931.28% |
| 2018 | -148.42 Million CNY | 75.83% |
| 2017 | -614.09 Million CNY | 6.53% |
| 2016 | -656.96 Million CNY | 18.71% |
| 2015 | -808.18 Million CNY | 16.4% |
| 2014 | -966.68 Million CNY | 20.14% |
| 2013 | -1.21 Billion CNY | 4.61% |
| 2012 | -1.26 Billion CNY | 12.66% |
| 2011 | -1.45 Billion CNY | 10.09% |
| 2010 | -1.61 Billion CNY | -828.97% |
| 2009 | -173.94 Million CNY | -207.78% |
| 2008 | -56.51 Million CNY | 58.89% |
| 2007 | -137.48 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 5.71 Billion CNY | 440.64% |
| 2024 Q1 | 2.06 Billion CNY | 162.46% |
| 2024 Q2 | -1.68 Billion CNY | -181.6% |
| 2023 Q4 | -3.3 Billion CNY | -330.28% |
| 2023 Q1 | 1.29 Billion CNY | 319.79% |
| 2023 FY | -3.3 Billion CNY | -461.19% |
| 2023 Q2 | -205.44 Million CNY | -115.87% |
| 2023 Q3 | 1.43 Billion CNY | 798.57% |
| 2022 Q3 | -616.16 Million CNY | 3.24% |
| 2022 Q2 | -636.82 Million CNY | -242.44% |
| 2022 FY | -588.93 Million CNY | 83.13% |
| 2022 Q1 | 447.09 Million CNY | 112.81% |
| 2022 Q4 | -588.93 Million CNY | 4.42% |
| 2021 FY | -3.48 Billion CNY | -342.95% |
| 2021 Q3 | -3.72 Billion CNY | -12.64% |
| 2021 Q4 | -3.48 Billion CNY | 6.24% |
| 2021 Q2 | -3.3 Billion CNY | -237.91% |
| 2021 Q1 | 2.39 Billion CNY | 66.8% |
| 2020 Q2 | 2.73 Billion CNY | 7.04% |
| 2020 Q4 | 1.43 Billion CNY | -32.37% |
| 2020 FY | 1.43 Billion CNY | 16.43% |
| 2020 Q1 | 2.55 Billion CNY | 106.8% |
| 2020 Q3 | 2.12 Billion CNY | -22.23% |
| 2019 Q2 | 1.24 Billion CNY | 67.28% |
| 2019 Q4 | 1.23 Billion CNY | -9.96% |
| 2019 FY | 1.23 Billion CNY | 931.28% |
| 2019 Q1 | 742.45 Million CNY | 600.22% |
| 2019 Q3 | 1.37 Billion CNY | 10.33% |
| 2018 Q3 | -33.62 Million CNY | 76.39% |
| 2018 FY | -148.42 Million CNY | 75.83% |
| 2018 Q4 | -148.42 Million CNY | -341.43% |
| 2018 Q2 | -142.38 Million CNY | 76.39% |
| 2018 Q1 | -603 Million CNY | 1.81% |
| 2017 Q2 | -531.32 Million CNY | 10.2% |
| 2017 Q3 | -579.83 Million CNY | -9.13% |
| 2017 Q4 | -614.09 Million CNY | -5.91% |
| 2017 FY | -614.09 Million CNY | 6.53% |
| 2017 Q1 | -591.66 Million CNY | 9.94% |
| 2016 Q2 | -692.04 Million CNY | 8.22% |
| 2016 Q4 | -656.96 Million CNY | -6.43% |
| 2016 FY | -656.96 Million CNY | 18.71% |
| 2016 Q3 | -617.29 Million CNY | 10.8% |
| 2016 Q1 | -754.06 Million CNY | 6.8% |
| 2015 Q3 | -711.58 Million CNY | 7.86% |
| 2015 FY | -808.18 Million CNY | 16.4% |
| 2015 Q1 | -856.5 Million CNY | 11.4% |
| 2015 Q2 | -772.3 Million CNY | 9.83% |
| 2015 Q4 | -809.07 Million CNY | -13.7% |
| 2014 Q4 | -966.68 Million CNY | -10.21% |
| 2014 Q2 | -965.08 Million CNY | 6.52% |
| 2014 Q1 | -1.03 Billion CNY | 14.71% |
| 2014 FY | -966.68 Million CNY | 20.14% |
| 2014 Q3 | -877.15 Million CNY | 9.11% |
| 2013 Q3 | -984.86 Million CNY | 12.95% |
| 2013 Q1 | -1.21 Billion CNY | 4.62% |
| 2013 FY | -1.21 Billion CNY | 4.61% |
| 2013 Q4 | -1.21 Billion CNY | -22.9% |
| 2013 Q2 | -1.13 Billion CNY | 6.53% |
| 2012 Q3 | -1.28 Billion CNY | -0.03% |
| 2012 Q4 | -1.26 Billion CNY | 0.87% |
| 2012 FY | -1.26 Billion CNY | 12.66% |
| 2012 Q2 | -1.27 Billion CNY | 9.01% |
| 2012 Q1 | -1.4 Billion CNY | 3.19% |
| 2011 Q3 | -1.44 Billion CNY | -1.95% |
| 2011 Q2 | -1.41 Billion CNY | 9.33% |
| 2011 Q1 | -1.56 Billion CNY | 3.34% |
| 2011 FY | -1.45 Billion CNY | 10.09% |
| 2011 Q4 | -1.45 Billion CNY | -0.62% |
| 2010 Q4 | -1.61 Billion CNY | 1.95% |
| 2010 FY | -1.61 Billion CNY | -828.97% |
| 2010 Q2 | -232.78 Million CNY | 0.0% |
| 2010 Q3 | -1.64 Billion CNY | -607.92% |
| 2009 Q4 | -173.94 Million CNY | 0.0% |
| 2009 FY | -173.94 Million CNY | -207.78% |
| 2008 FY | -56.51 Million CNY | 58.89% |
| 2007 FY | -137.48 Million CNY | 0.0% |